Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 14(7): e0219011, 2019.
Article in English | MEDLINE | ID: mdl-31269046

ABSTRACT

Cardiac fibroblasts (CF) play a critical role in post-infarction remodeling which can ultimately lead to pathological fibrosis and heart failure. Recent evidence demonstrates that remote (non-infarct) territory fibrosis is a major mechanism for ventricular dysfunction and arrhythmogenesis. ß-arrestins are important signaling molecules involved in ß-adrenergic receptor (ß-AR) desensitization and can also mediate signaling in a G protein independent fashion. Recent work has provided evidence that ß-arrestin signaling in the heart may be beneficial, however, these studies have primarily focused on cardiac myocytes and their role in adult CF biology has not been well studied. In this study, we show that ß-arrestins can regulate CF biology and contribute to pathological fibrosis. Adult male rats underwent LAD ligation to induce infarction and were studied by echocardiography. There was a significant decline in LV function at 2-12 weeks post-MI with increased infarct and remote territory fibrosis by histology consistent with maladaptive remodeling. Collagen synthesis was upregulated 2.9-fold in CF isolated at 8 and 12 weeks post-MI and ß-arrestin expression was significantly increased. ß-adrenergic signaling was uncoupled in the post-MI CF and ß-agonist-mediated inhibition of collagen synthesis was lost. Knockdown of ß-arrestin1 or 2 in the post-MI CF inhibited transformation to myofibroblasts as well as basal and TGF-ß-stimulated collagen synthesis. These data suggest that ß-arrestins can regulate CF biology and that targeted inhibition of these signaling molecules may represent a novel approach to prevent post-infarction pathological fibrosis and the transition to HF.


Subject(s)
Ventricular Remodeling/physiology , beta-Arrestin 1/physiology , beta-Arrestin 2/physiology , Actins/metabolism , Animals , Collagen Type I/biosynthesis , Disease Models, Animal , Fibroblasts/physiology , Gene Knockdown Techniques , Heart Failure/etiology , Heart Failure/pathology , Heart Failure/physiopathology , Male , Myocardial Infarction/complications , Myocardial Infarction/pathology , Myocardial Infarction/physiopathology , Myocardium/cytology , Myocardium/metabolism , Myocytes, Cardiac/physiology , Myofibroblasts/pathology , Myofibroblasts/physiology , Rats , Rats, Sprague-Dawley , Signal Transduction , Transforming Growth Factor beta/metabolism , beta-Arrestin 1/antagonists & inhibitors , beta-Arrestin 1/genetics , beta-Arrestin 2/antagonists & inhibitors , beta-Arrestin 2/genetics
2.
Pharmacol Res Perspect ; 7(4): e00497, 2019 08.
Article in English | MEDLINE | ID: mdl-31236278

ABSTRACT

Tobacco kills 6 million people annually and its global health costs are continuously rising. The main addictive component of every tobacco product is nicotine. Among the mechanisms by which nicotine, and its major metabolite, cotinine, contribute to heart disease is the renin-angiotensin-aldosterone system (RAAS) activation. This increases aldosterone production from the adrenals and circulating aldosterone levels. Aldosterone is a mineralocorticoid hormone with various direct harmful effects on the myocardium, including increased reactive oxygen species (ROS) generation, which contributes significantly to cardiac mitochondrial dysfunction and cardiac aging. Aldosterone is produced in the adrenocortical zona glomerulosa (AZG) cells in response to angiotensin II (AngII), activating its type 1 receptor (AT1R). The AT1R is a G protein-coupled receptor (GPCR) that leads to aldosterone biosynthesis and secretion, via signaling from both Gq/11 proteins and the GPCR adapter protein ßarrestin1, in AZG cells. Adrenal ßarrestin1 is essential for AngII-dependent adrenal aldosterone production, which aggravates heart disease. Since adrenal ßarrestin1 is essential for raising circulating aldosterone in the body and tobacco compounds are also known to elevate aldosterone levels in smokers, accelerating heart disease progression, our central hypothesis is that nicotine and cotinine increase aldosterone levels to induce cardiac injury by stimulating adrenal ßarrestin1. In the present review, we provide an overview of the current literature of the physiology and pharmacology of adrenal aldosterone production regulation, of the effects of tobacco on this process and, finally, of the effects of tobacco and aldosterone on cardiac structure and function, with a particular focus on cardiac mitochondrial function. We conclude our literature account with a brief experimental outline, as well as with some therapeutic perspectives of our pharmacological hypothesis, that is that adrenal ßarrestin1 is a novel molecular target for preventing tobacco-induced hyperaldosteronism, thereby also ameliorating tobacco-related heart disease development.


Subject(s)
Aldosterone/metabolism , Heart Diseases/metabolism , Nicotiana/adverse effects , beta-Arrestin 1/metabolism , Adrenal Glands/metabolism , Cotinine/adverse effects , Heart Diseases/chemically induced , Heart Diseases/drug therapy , Humans , Molecular Targeted Therapy , Nicotine/adverse effects , Nicotiana/chemistry , beta-Arrestin 1/antagonists & inhibitors
3.
Elife ; 62017 07 27.
Article in English | MEDLINE | ID: mdl-28749339

ABSTRACT

PTEN controls three-dimensional (3D) glandular morphogenesis by coupling juxtamembrane signaling to mitotic spindle machinery. While molecular mechanisms remain unclear, PTEN interacts through its C2 membrane-binding domain with the scaffold protein ß-Arrestin1. Because ß-Arrestin1 binds and suppresses the Cdc42 GTPase-activating protein ARHGAP21, we hypothesize that PTEN controls Cdc42 -dependent morphogenic processes through a ß-Arrestin1-ARHGAP21 complex. Here, we show that PTEN knockdown (KD) impairs ß-Arrestin1 membrane localization, ß-Arrestin1-ARHGAP21 interactions, Cdc42 activation, mitotic spindle orientation and 3D glandular morphogenesis. Effects of PTEN deficiency were phenocopied by ß-Arrestin1 KD or inhibition of ß-Arrestin1-ARHGAP21 interactions. Conversely, silencing of ARHGAP21 enhanced Cdc42 activation and rescued aberrant morphogenic processes of PTEN-deficient cultures. Expression of the PTEN C2 domain mimicked effects of full-length PTEN but a membrane-binding defective mutant of the C2 domain abrogated these properties. Our results show that PTEN controls multicellular assembly through a membrane-associated regulatory protein complex composed of ß-Arrestin1, ARHGAP21 and Cdc42.


Subject(s)
Cell Membrane/metabolism , GTPase-Activating Proteins/genetics , Organoids/metabolism , PTEN Phosphohydrolase/genetics , Spindle Apparatus/metabolism , beta-Arrestin 1/genetics , Animals , Binding Sites , Caco-2 Cells , Cell Membrane/ultrastructure , GTPase-Activating Proteins/antagonists & inhibitors , GTPase-Activating Proteins/metabolism , Gene Expression Regulation , HCT116 Cells , HEK293 Cells , Humans , Mice , Mice, Inbred C57BL , Organoids/cytology , Organoids/ultrastructure , PTEN Phosphohydrolase/antagonists & inhibitors , PTEN Phosphohydrolase/metabolism , Protein Binding , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Signal Transduction , Spindle Apparatus/ultrastructure , Tissue Culture Techniques , beta-Arrestin 1/antagonists & inhibitors , beta-Arrestin 1/metabolism , cdc42 GTP-Binding Protein/genetics , cdc42 GTP-Binding Protein/metabolism
4.
Biochem Biophys Res Commun ; 483(1): 75-81, 2017 01 29.
Article in English | MEDLINE | ID: mdl-28062183

ABSTRACT

Recent evidence suggests that ß-arrestins, which are involved in G protein-coupled receptors desensitization, may influence mechanotransduction. Here, we observed that nitric oxide (NO) production was abrogated in human saphenous vein endothelial cells (SVECs) transfected with siRNA against ß-arrestin 1 and 2 subjected to shear stress (SS, 15 dynes/cm2, 10 min). The downregulation of ß-arrestins 1/2 in SVECs cells also prevented the SS-induced rise in levels of phosphorylation of Akt and endothelial nitric oxide synthase (eNOS, Serine 1177). Interestingly, immunoprecipitation revealed that ß-arrestin interacts with Akt, eNOS and caveolin-1 and these interactions are not influenced by SS. Our data indicate that ß-arrestins and Akt/eNOS downstream signaling are required for early SS-induced NO production in SVECs, which is consistent with the idea that ß-arrestins and caveolin-1 are part of a pre-assembled complex associated with the cellular mechanotransduction machinery.


Subject(s)
Endothelial Cells/metabolism , Nitric Oxide Synthase Type III/metabolism , Proto-Oncogene Proteins c-akt/metabolism , beta-Arrestin 1/metabolism , beta-Arrestin 2/metabolism , Caveolin 1/metabolism , Cells, Cultured , Down-Regulation , Humans , Mechanotransduction, Cellular/physiology , Phosphorylation , RNA, Small Interfering/genetics , Signal Transduction , Stress, Mechanical , beta-Arrestin 1/antagonists & inhibitors , beta-Arrestin 1/genetics , beta-Arrestin 2/antagonists & inhibitors , beta-Arrestin 2/genetics
5.
Sci Rep ; 6: 35808, 2016 10 26.
Article in English | MEDLINE | ID: mdl-27782165

ABSTRACT

Impaired phosphatase activity leads to the persistent activation of signal transducers and activators of transcription (Stat). In mammals, Stat family members are often phosphorylated or dephosphorylated by the same enzymes. To date, only one Stat similar to mammalian Stat5a/b has been found in crustaceans and there have been few studies in Stat signal regulation in crustaceans. Here, we report that ß-arrestin1 interacts with TC45 (45-kDa form of T cell protein tyrosine phosphatase) in the nucleus to attenuate Stat signaling by promoting dephosphorylation of Stat. Initially, we showed that Stat translocates into the nucleus to induce antimicrobial peptide (AMP) expression after bacterial infection. ßArr1 enters the nucleus of hemocytes and recruits TC45 to form the ßarr1-TC45-Stat complex, which dephosphorylates Stat efficiently. The interaction of TC45 with Stat decreased and Stat phosphorylation increased in ßarr1-silenced shrimp (Marsupenaeus japonicus) after challenge with Vibrio anguillarum. ßArr1 directly interacts with Stat in nucleus and accelerates Stat dephosphorylation by recruiting TC45 after V. anguillarum challenge. Further study showed that ßarr1 and TC45 also affect AMP expression, which is regulated by Stat. Therefore, ßarr1 and TC45 are involved in the anti-V. anguillarum immune response by regulating Stat activity negatively to decrease AMP expression in shrimp.


Subject(s)
Antimicrobial Cationic Peptides/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 2/metabolism , STAT Transcription Factors/metabolism , beta-Arrestin 1/metabolism , Animals , Chlorocebus aethiops , Decapoda/metabolism , Intestinal Mucosa/metabolism , Phosphorylation , Protein Binding , Protein Domains , Protein Tyrosine Phosphatase, Non-Receptor Type 2/antagonists & inhibitors , Protein Tyrosine Phosphatase, Non-Receptor Type 2/genetics , RNA Interference , RNA, Messenger/metabolism , RNA, Small Interfering/metabolism , STAT Transcription Factors/antagonists & inhibitors , STAT Transcription Factors/genetics , Signal Transduction , Vibrio/physiology , beta-Arrestin 1/antagonists & inhibitors , beta-Arrestin 1/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...